Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

110.48
-0.0588-0.05%
Volume:88.25K
Turnover:9.79M
Market Cap:1.00B
PE:89.52
High:111.34
Open:110.76
Low:110.39
Close:110.53
52wk High:118.00
52wk Low:85.91
Shares:9.09M
Float Shares:9.09M
Volume Ratio:0.52
T/O Rate:0.97%
Dividend:2.18
Dividend Rate:1.97%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):142.28

Loading ...

Novartis Halts ALS Drug Development After Phase 2 Trial Miss

MT Newswires Live
·
2 hours ago

Will AI Save the Pharma Industry Billions? Novo's Anthropic Deal is Betting on It.

Dow Jones
·
2 hours ago

Novo Nordisk Will Use Anthropic's Claude for Drug Research

Dow Jones
·
2 hours ago

Novartis AG Rises Wednesday

Dow Jones
·
2 hours ago

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
2 hours ago

Novartis to End ALS Trial Amid String of Study Failures

Dow Jones
·
Yesterday

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Circle Pharma Raises $92.5 Million in Series E Funding Led by Column Group

Reuters
·
Yesterday

Novo Nordisk announces collaboration with Anthropic

TIPRANKS
·
Yesterday

Twist Bioscience Corporation - to Provide Antibody Characterization Data Services for Lilly Tunelab

THOMSON REUTERS
·
Yesterday

Circle Pharma: Financing Led by Column Group, Participation from Nextech Invest, Ra Capital Management, Strategic Investment from Eli Lilly and Co

THOMSON REUTERS
·
Yesterday

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
Yesterday

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
Yesterday

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Sep 15

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Sep 15

Novo CEO Urges Staff to Embrace More Customer-Focused Culture

Reuters
·
Sep 15

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
Sep 15